OS Therapies to Present at The Spartan Capital Investor Conference
OS Therapies Incorporated (OSTX)
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that Paul Romness, Chief Executive Officer, and Gerald Commissiong, Chief Business Officer, will present a corporate overview at The Spartan Capital Investor Conference. The conference is being held on November 4, 2024 at the Pierre Hotel in New York. The Company’s participation aligns with our commitment to engage with industry leaders and investors.Event:The Spartan Capital Investor Conference Presentation Date:Monday, November 4, 2024 Time:4:45 PM ETMr. Romness and Mr. Commissiong will be available for one-on-one meetings with registered investors of the conference.The conference, organized in partnership with B2i Digital, a leading digital marketing firm specializing in investor communications, will feature presentations from over 30 carefully selected companies. The event will in
Show less
Read more
Impact Snapshot
Event Time:
OSTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OSTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OSTX alerts
High impacting OS Therapies Incorporated news events
Weekly update
A roundup of the hottest topics
OSTX
News
- OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateBusiness Wire
- Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30Business Wire
- OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of DirectorsBusiness Wire
- OS Therapies to Present at the LD Micro Main Event XVIIBusiness Wire
- OS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitBusiness Wire
OSTX
Earnings
- 11/15/24 - Miss
OSTX
Sec Filings
- 11/15/24 - Form 8-K
- 11/15/24 - Form 10-Q
- 11/14/24 - Form NT
- OSTX's page on the SEC website